Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Hodgkin Disease 65Lymphoma 39Urinary Bladder Neoplasms 16Carcinoma, Non-Small-Cell Lung 10Melanoma 9Lung Neoplasms 9Urethral Neoplasms 4Recurrence 4Prostatic Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Testicular Neoplasms 3Neoplasms 3Leukemia 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Testicular Germ Cell Tumor 2Teratoma 2Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Kidney Neoplasms 2HIV Infections 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Ureteral Neoplasms 1Survival Without Progression 1

Interventions

Docetaxel 277Prednisone 236enzalutamide 175Leuprolide 172Radiotherapy 164Abiraterone Acetate 153Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 78abiraterone 75gallium 68 PSMA-11 74Specimen Handling 67Gonadotropin-Releasing Hormone 58darolutamide 56Radiation 56Triptorelin Pamoate 53cabazitaxel 49Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Vinblastine × Clear all
NCT00030654 2020-10-22

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
306 enrolled
Genitourinary

Prostatic Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
265 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT00003084 2012-07-30

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
75 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡